Literature DB >> 26438526

NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin.

Federico Simonetta1, Amandine Pradier2, Carine Bosshard2, Stavroula Masouridi-Levrat2, Yves Chalandon2, Eddy Roosnek2.   

Abstract

NK cells play a major role in protection against tumor recurrence and infection after allogeneic hematopoietic stem cell transplantation (HSCT). It has been shown that NK cell function after HSCT is impaired, but underlying molecular mechanisms are not well-known. In this report we show that the level of T-bet and Eomesodermin (Eomes), two T-box transcription factors regulating lymphocyte effector functions, is strongly reduced in NK cells from HSCT recipients compared with healthy control subjects. Reduction of T-bet and Eomes expression appeared early and persisted for years after HSCT, affecting all peripheral blood NK cells independently of their differentiation status. Reduced T-bet levels in NK cells from allogeneic HSCT recipients significantly correlated with reduced perforin expression. Acute, but not chronic, graft-versus-host disease, as well as CMV reactivation, was associated with further downregulation of T-bet expression in NK cells. Lower levels of T-bet expression in NK cells were associated with less favorable outcome after HSCT as a result of increased nonrelapse mortality. Collectively, our results provide a possible molecular explanation for the previously reported functional exhaustion of NK cells after allogeneic HSCT and suggest an impact of the NK transcriptional machinery status on HSCT outcome.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26438526     DOI: 10.4049/jimmunol.1501522

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Fewer Circulating Natural Killer Cells 28 Days After Double Cord Blood Transplantation Predicts Inferior Survival and IL-15 Response.

Authors:  Rachel J Bergerson; Robin Williams; Hongbo Wang; Ryan Shanley; Gretchen Colbenson; Alyssa Kerber; Sarah Cooley; Julie Curtsinger; Martin Felices; Jeffrey S Miller; Michael R Verneris
Journal:  Blood Adv       Date:  2016-10-30

2.  Genome-wide analyses and functional profiling of human NK cell lines.

Authors:  Justin T Gunesch; Laura S Angelo; Sanjana Mahapatra; Raquel P Deering; Johanna E Kowalko; Patrick Sleiman; John W Tobias; Linda Monaco-Shawver; Jordan S Orange; Emily M Mace
Journal:  Mol Immunol       Date:  2018-07-24       Impact factor: 4.407

3.  Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway.

Authors:  Maite Alvarez; Federico Simonetta; Jeanette Baker; Antonio Pierini; Arielle S Wenokur; Alyssa R Morrison; William J Murphy; Robert S Negrin
Journal:  JCI Insight       Date:  2019-06-18

Review 4.  The Role of NK Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia.

Authors:  Alireza Zafarani; Mahsa Taghavi-Farahabadi; Mohammad Hossein Razizadeh; Mohammad Reza Amirzargar; Mansoure Mansouri; Mohammad Mahmoudi
Journal:  Stem Cell Rev Rep       Date:  2022-08-22       Impact factor: 6.692

5.  Human Term Pregnancy Decidual NK Cells Generate Distinct Cytotoxic Responses.

Authors:  Ricardo de Mendonça Vieira; Ava Meagher; Ângela C Crespo; Sarika K Kshirsagar; Vidya Iyer; Errol R Norwitz; Jack L Strominger; Tamara Tilburgs
Journal:  J Immunol       Date:  2020-05-06       Impact factor: 5.422

6.  Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma.

Authors:  Jennifer A Foltz; Brian T Hess; Veronika Bachanova; Nancy L Bartlett; Melissa M Berrien-Elliott; Ethan McClain; Michelle Becker-Hapak; Mark Foster; Timothy Schappe; Brad Kahl; Neha Mehta-Shah; Amanda F Cashen; Nancy D Marin; Kristen McDaniels; Chaz Moreno; Matthew Mosior; Feng Gao; Obi L Griffith; Malachi Griffith; Julia A Wagner; Narendranath Epperla; Amy D Rock; John Lee; Allegra A Petti; Patrick Soon-Shiong; Todd A Fehniger
Journal:  Clin Cancer Res       Date:  2021-04-08       Impact factor: 12.531

7.  Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for Leukemia.

Authors:  Melissa M Berrien-Elliott; Amanda F Cashen; Celia C Cubitt; Carly C Neal; Pamela Wong; Julia A Wagner; Mark Foster; Timothy Schappe; Sweta Desai; Ethan McClain; Michelle Becker-Hapak; Jennifer A Foltz; Matthew L Cooper; Natalia Jaeger; Sridhar Nonavinkere Srivatsan; Feng Gao; Rizwan Romee; Camille N Abboud; Geoffrey L Uy; Peter Westervelt; Meagan A Jacoby; Iskra Pusic; Keith E Stockerl-Goldstein; Mark A Schroeder; John DiPersio; Todd A Fehniger
Journal:  Cancer Discov       Date:  2020-08-21       Impact factor: 38.272

8.  TIGIT+ TIM-3+ NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma.

Authors:  Lihua Yu; Xiaoli Liu; Xinhui Wang; Fengna Yan; Peng Wang; Yuyong Jiang; Juan Du; Zhiyun Yang
Journal:  Oncoimmunology       Date:  2021-06-28       Impact factor: 8.110

9.  OMIP-080: 29-Color flow cytometry panel for comprehensive evaluation of NK and T cells reconstitution after hematopoietic stem cells transplantation.

Authors:  Sarka Vanikova; Abhishek Koladiya; Jan Musil
Journal:  Cytometry A       Date:  2021-10-24       Impact factor: 4.714

Review 10.  Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Md Ashik Ullah; Geoffrey R Hill; Siok-Keen Tey
Journal:  Front Immunol       Date:  2016-04-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.